Literature DB >> 1106353

Discontinuance of immunosuprression in renal transplant patients.

M L Owens, J G Maxwell, J Goodnight, M W Wolcott.   

Abstract

Immunosuppressive therapy was discontinued in six patients for an average of 27 months. In these six patients, only two rejections have occurred. A survey of other transplant centers showed that in such patients rejection was often delayed weeks or months after therapy was stopped. Once immunosuppressive therapy has been stopped, for whatever reason, and rejection has not occurred, consideration should be given to not resuming therapy unless signs of rejection appear.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1106353     DOI: 10.1001/archsurg.1975.01360180020004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  13 in total

1.  Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.

Authors:  Pervinder Sagoo; Esperanza Perucha; Birgit Sawitzki; Stefan Tomiuk; David A Stephens; Patrick Miqueu; Stephanie Chapman; Ligia Craciun; Ruhena Sergeant; Sophie Brouard; Flavia Rovis; Elvira Jimenez; Amany Ballow; Magali Giral; Irene Rebollo-Mesa; Alain Le Moine; Cecile Braudeau; Rachel Hilton; Bernhard Gerstmayer; Katarzyna Bourcier; Adnan Sharif; Magdalena Krajewska; Graham M Lord; Ian Roberts; Michel Goldman; Kathryn J Wood; Kenneth Newell; Vicki Seyfert-Margolis; Anthony N Warrens; Uwe Janssen; Hans-Dieter Volk; Jean-Paul Soulillou; Maria P Hernandez-Fuentes; Robert I Lechler
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 2.  Operational tolerance in kidney transplantation and associated biomarkers.

Authors:  A Massart; L Ghisdal; M Abramowicz; D Abramowicz
Journal:  Clin Exp Immunol       Date:  2017-05-29       Impact factor: 4.330

3.  Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.

Authors:  D Berglund; M Karlsson; A-R Biglarnia; T Lorant; G Tufveson; O Korsgren; B Carlsson
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

Review 4.  Tolerance signatures in transplant recipients.

Authors:  Kenneth A Newell; Laurence A Turka
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

5.  Serious renal transplant rejection and adrenal hypofunction after gradual withdrawal of prednisolone two years after transplantation.

Authors:  R B Naik; J Chakraborty; J English; V Marks; M Slapak; H A Lee
Journal:  Br Med J       Date:  1980-06-07

Review 6.  Tolerance in clinical transplantation: progress, challenge or just a dream?

Authors:  Fred Fändrich
Journal:  Langenbecks Arch Surg       Date:  2011-03-17       Impact factor: 3.445

Review 7.  Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients.

Authors:  Kenneth A Newell; Andrew B Adams; Laurence A Turka
Journal:  Hum Immunol       Date:  2018-02-12       Impact factor: 2.850

Review 8.  Clinical operational tolerance after renal transplantation: current status and future challenges.

Authors:  Giuseppe Orlando; Peiman Hematti; Robert J Stratta; George W Burke; Pierpaolo Di Cocco; Pierpaolo Di Cocco; Francesco Pisani; Shay Soker; Kathryn Wood
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

Review 9.  Clinical transplantation tolerance.

Authors:  Kenneth A Newell
Journal:  Semin Immunopathol       Date:  2011-02-14       Impact factor: 9.623

10.  Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.

Authors:  D P Singal; M A Blajchman; S Joseph; B Roberge; E K Smith; D Ludwin
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.